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Background: Excessive pro-inflammatory cytokine production from activated microglia contributes to neurodegenerative
diseases, thus, microglial inactivation may delay the progress of neurodegeneration by attenuating the
neuroinflammation. Among 5 selected brown algae, we found the highest antioxidant and anti-neuroinflammatory
activities from Myagropsis myagroides ethanolic extract (MME) in lipopolysaccharide (LPS)-stimulated BV-2 cells.
Methods: The levels of nitric oxide (NO), prostaglandin E2 (PGE2), and pro-inflammatory cytokines were measured by
Griess assay and enzyme linked immunesorbent assay. The levels of inducible nitric oxide synthase (iNOS),
cyclooxygenase-2 (COX-2), mitogen-activated protein kinases (MAPKs), and Akt were measured using Western blot.
Nuclear translocation and transcriptional activation of nuclear factor-κB (NF-κB) were determined by immunefluorescence
and reporter gene assay, respectively.
Results: MME inhibited the expression of iNOS and COX-2 at mRNA and protein levels, resulting in reduction of NO and
PGE2 production. As a result, pro-inflammatory cytokines were reduced by MME. MME also inhibited the activation and
translocation of NF-κB by preventing inhibitor κB-α (IκB-α) degradation. Moreover, MME inhibited the phosphorylation of
extracellular signal regulated kinases (ERKs) and c-Jun N-terminal kinases (JNKs). Main anti-inflammatory compound in MME
was identified as sargachromenol by NMR spectroscopy.
Conclusions: These results indicate that the anti-inflammatory effect of sargachromenol-rich MME on LPS-stimulated
microglia is mainly regulated by the inhibition of IκB-α/NF-κB and ERK/JNK pathways.
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NeuroinflammationBackground
Microglia, a macrophage-like cells in the brain, play a
pivotal role in the innate immune response in the cen-
tral nervous system. Microglia are activated by the broad
spectrum of stimuli such as lipopolysaccharide (LPS),
interferon-γ, or β-amyloid [1,2]. Activated microglia pro-
duce various neurotoxic factors including inflammatory
mediators such as nitric oxide (NO) and prostaglandin E2
(PGE2), and pro-inflammatory cytokines such as tumor
necrosis factor-α (TNF-α), interleukin (IL)-1β, and IL-6* Correspondence: hrkim@pknu.ac.kr
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unless otherwise stated.[3,4]. Pathogenic roles of inflammatory mediators and cy-
tokines have been implicated in various inflammatory and
neurodegenerative diseases, including Alzheimer’s disease,
Parkinson’s disease, trauma, multiple sclerosis, and cere-
bral ischemia [5,6].Therefore, the modulation of microglial
activation is important for the prevention or relief of
neuroinflammation.
The induction of inflammatory proteins and pro-
inflammatory cytokines are primarily controlled at tran-
scriptional level [7]. Transcriptional induction of inducible
nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-
2) is largely dependent on cooperative activities of mul-
tiple transcription factors, including nuclear factor-κB
(NF-κB) and activator protein 1 which act on cognate. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[7,8]. NF-κB plays key roles in early stage of immune
and inflammatory responses as well as cell survival
[9,10]. In unstimulated conditions, NF-κB bound with
inhibitory kappaB-α (IκB-α) is located in the cytoplasm
as an inactive complex. Exposure to LPS stimulates
phosphorylation, ubiquitination, and degradation of
IκB-α, resulting in nuclear translocation of NF-κB by
dissociation of NF-κB-IκB-α complex for the transcrip-
tion of target genes [11]. The activation of NF-κB is
also regulated by cellular kinases such as mitogen-
activated protein kinases (MAPKs) [12]. The MAPKs
such as extracellular signal-regulated kinase (ERK),
p38 MAPK, and c-Jun NH2-terminal kinase (JNK) have
been involved in the transcriptional regulations of in-
flammatory genes [12,13].
Marine macroalgae have been used as a healthy diet in
East Asia for centuries. Recently, various studies re-
vealed that their constituents such as phlorotannins and
pigments showed diverse biological activities including
antioxidation [14-16] and anti-inflammation [15,17-20].
Myagropsis myagroides, growing subtidal zone of the
coast of East Asia, belongs to the family Sargassaceae in
Phaeophyta. It shows the anti-inflammatory activity and
its active compound was tentatively identified as phloro-
fucofuroeckol B by NMR spectroscopy and 6,6’-bieckol
[21,22]. However, we found that M. myagroides ethanolic
extract (MME) showed higher anti-inflammatory activity
than phlorofucofuroeckol B and 6,6’-bieckol and the
isolated compound was identified as sargachromenol.
Biological activities of sargachromenol were limited to
anti-photoaging activity [23], anti-cholinesterase activity
[24], and neuronal growth factor [25]. To our knowledge, no
previous study has been reported on the anti-inflammatory
activity of sargachromenol-rich MME in LPS-treated BV-2
cells. BV-2 cells, derived from primary mouse microglia
cells, are considered as a reasonable model for in vitro
pharmacological studies, since their response to LPS
showed a similar pattern to primary microglia in vivo
based on transcriptome and proteome analysis [26].
With respective to neurodegeneration studies, acti-
vated BV-2 cells by LPS secret pro-inflammatory cyto-
kines, which have been shown to promote neuronal
injury at high level [27]. This led us to evaluate the in-
hibitory effect of MME on inflammation using BV-2
cells, and we further investigated the possible molecu-
lar mechanisms underlying its anti-inflammatory ac-
tion on cultured BV-2 cells.
Methods
Algae materials and preparation of ethanolic extracts
Myagropsis myagroides (MBRB0078-TC10499), Undaria
pinnatifida (MBRB0049-TC9322), Saccharina japonica
(MBRM0094-TC11278), Sargassum horneri (MBRB0037-TC9244), and S. fulvellum (MBRB00112-TC7337) were
collected along the coast of Busan, South Korea from
January to August 2012. Taxonomic identification of the
collected seaweeds was authenticated by an agal tax-
onomist (C.G. Choi), at the Department of Ecological
Engineering, Pukyong National University, South Korea.
Voucher specimens were deposited in the Marine Brown
Algae Resources Bank, South Korea. The collected sea-
weeds were sun-dried for 3 days and ground with ham-
mer mill. Each dried powder (100 g) was extracted
three times with 500 mL of ethanol (95%, v/v) for 3 h
at 70°C. The combined extracts were concentrated
using a rotary vacuum evaporator (Eyela, Tokyo, Japan) at
40°C and lyophilized to obtain the ethanolic extracts of
seaweed.Chemicals
Cell culture medium and all the other materials required
for cell culture were purchased from Gibco BRL Life
Technologies (Grand Island, NY, USA). LPS (Escherichia
coli O55:B5), dimethyl sulfoxide (DMSO), bovine serum
albumin (BSA), and the specific protein kinase inhibitors
(PD98059 and SP600125) were purchased from Sigma
Chemical Co. (St. Louis, MO, USA). CellTiter96 AQueous
One Solution Cell Proliferation assay kit, dual-luciferase
assay system, murine NF-κB promoter/luciferase DNA,
pRL-TK DNA, and moloney murine leukemia virus
(M-MLV) reverse transcriptase were obtained from
Promega (Madison, WI, USA). Enzyme-linked immuno-
sorbent assay (ELISA) kits for TNF-α, IL-1β, and IL-6
were obtained from eBioscience (San Diego, CA, USA)
and PGE2 ELISA kit was purchased from R&D Systems
(Minneapolis, MN, USA). Primary and secondary anti-
bodies were purchased from Cell Signaling Biotechnology
(Danvers, MA, USA) and Santa Cruz Biotechnology
(Santa Cruz, CA, USA), respectively. 4’,6-Diamidino-2-
phenylindole (DAPI), Lipofectamine Plus Reagent, TRIzol,
and Alexa Fluor® 488-conjugated secondary antibody
were purchased from Invitrogen (Carlsbad, CA, USA).
The enhanced chemiluminescence (ECL) detection kit was
purchased from GE Healthcare Life Sciences (Piscataway,
NJ, USA).Measurement of total phenolic content
Total phenolic content was measured according to the
method of Koivikko et al. (2005) [28]. In brief, diluted
sample 0.5 mL was mixed with 0.5 mL of 1 N Folin-
Ciacalteu solution and incubated at 37°C. After 5 min,
1.0 mL of 20% sodium carbonate was added and the
mixture was incubated for 30 min. The absorbance was
measured at 730 nm, and total phenolic content was cal-
culated using a phloroglucinol (Sigma Chemical Co.) as
a standard.
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Murine BV-2 microglial cell lines were maintained in
Dulbecco’s Modified Eagle’s Medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS), penicillin
(100 units/mL), and streptomycin sulfate (100 μg/mL)
in a humidified atmosphere of 5% CO2. Cell viability was
determined by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-
methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS)
assay using CellTiter96 AQueous One Solution Cell Prolif-
eration assay kit according to the manufacturer’s manual.
Cells were inoculated at a density of 3 × 105 cells into
96-well plates and cultured at 37°C for 24 h. Cells were
then treated with LPS (1 μg/mL) in the presence or
absence of MME in different concentration for 24 h.
The final concentration of DMSO was less than 0.1%
in the cell culture medium. The culture medium was
removed and replaced by 95 μL of fresh culture medium
and 5 μL of MTS solution. After 1 h, the absorbance at
490 nm was measured using a microplate reader (Glomax
Multi Detection System, Promega).
Measurement of intracellular ROS
The intracellular ROS scavenging activity of the sample
was measured using the fluorescent probe 2’,7’-dichloro-
dihydrofluorescin diacetate (DCFH-DA). The cells were
incubated with different concentrations of extracts in
the absence or presence of LPS (1 μg/mL) for 2 h. Har-
vested cells by trypsin-EDTA solution [0.05% trypsin
and 0.02% EDTA in phosphate buffered saline (PBS)]
were washed twice with PBS and treated with 20 μM
DCFH-DA for 30 min at 37°C. The fluorescence inten-
sity was measured at excitation wavelength of 485 nm
and emission wavelength of 528 nm using a fluore-
scence microplate reader (Dual Scanning SPECTRAmax,
Molecular Devices Co., Sunnyvale, CA, USA). Relative
ROS level was adjusted with protein concentration of
cell lysates by BCA protein assay (Pierce Biotechnology,
Rockford, IL, USA).
Measurements of NO, PGE2 and pro-inflammatory
cytokines
Cells (5 × 104 cells/well) were pretreated with MME
(0–25 μg/mL) for 2 h prior to LPS treatment for 24 h.
After treatment of LPS, cultured media of BV-2 cells
were collected and stored at −72°C until tested. For
the measurement of NO, 100 μL of culture supernatant
was mixed with the same volume of Griess reagent
(0.1% naphthylethylenediamine dihydrochloride and
1% sulfanilamide in 5% phosphoric acid) and incubated
at room temperature for 10 min. Absorbance of the
mixture was measured with a microplate reader at
540 nm. Levels of PGE2, TNF-α, IL-1β, and IL-6 in culture
media from each group were quantitatively determined by
ELISA kit according to the manufacturer’s instructions.Western blot analysis
Proteins (30 μg) were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and trans-
ferred onto the nitrocellulose membranes. The mem-
branes were washed with Tris-buffered saline (10 mM
Tris–HCl, 150 mM NaCl, pH 7.5) supplemented with
0.05% Tween 20 (TBST) followed by blocking with
TBST containing 5% non-fat dried milk. The membranes
were incubated overnight with primary antibodies. After
washing three times with TBST, the membranes were then
exposed to secondary antibodies coupled to horseradish
peroxidase for 2 h at room temperature. The membranes
were washed three times with TBST at room temperature.
Immunoreactivities were detected by ECL reagents.
Densitometric analysis of the data obtained from at
least three independent experiments was performed
using cooled CCD camera system EZ-Capture II (ATTO
& Rise Co., Tokyo, Japan) and CS analyzer ver. 3.00 soft-
ware (ATTO & Rise Co.).
Reverse transcription-polymerase chain reaction (RT-PCR)
BV-2 cells plated in a 6-well cell culture plate at a dens-
ity of 3.0 × 105 cells/well were pretreated without or with
MME for 2 h and then treated with LPS for 6 h. Total
RNA from each group was isolated with the TRIzol re-
agent. Five micrograms of total RNA was used for reverse
transcription using oligo-dT and M-MLV reverse tran-
scriptase. PCR was carried out using the resulting cDNA
as a template, with the following condition: 25 cycles of
denaturation at 95°C for 30 s, annealing at 60°C for 30 s,
and extension at 72°C for 30 s. Verification of PCR prod-
uct of specific genes was established by their predicted
sizes under ultraviolet light illuminator. The primer se-
quences were following: 5’-ACC ACT CGT ACT TGG
GAT GC-3’ (sense), 5’-CAC CTT GGA GTT CAC CCA
GT-3’ (antisense) for iNOS (accession no. NM_010927); 5’-
TGG GCA AAG AAT GCA AAC AT-3’ (sense); 5’-CAG
CAA ATC CTT GCT GTT CC-3’ (antisense) for COX-2
(accession no. NM_011198); 5’-GAC CCC TTC ATT GAC
CTC AA-3’ (sense), 5’-CTT CTC CAT GGT GGT GAA
GA-3’ (antisense) for glyceraldehyde 3-phosphate dehydro-
genase (GAPDH) (accession no. NM_008084). GAPDH
was used as an internal standard to evaluate relative expres-
sion of COX-2 and iNOS. Densitometric analysis of the
data obtained from at least three independent experiments
was performed using CS analyzer ver. 3.00 software.
Immunofluorescence analysis
To analyze nuclear localization of NF-κB in BV-2 cells,
cells were cultured on glass coverslips (SPL Lifesciences
Co., Gyeonggi-do, Korea) in 24-well plates for 24 h.
After preincubation with MME for 2 h, cells were stimu-
lated with or without LPS (1 μg/mL) for 30 min. Cells
were fixed in 4.0% paraformaldehyde in PBS for 15 min
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Triton X-100 in PBS for 10 min. Permeabilized cells
were washed with PBS and blocked with 3% BSA in PBS
for 30 min. Thereafter, cells were incubated in an anti-
NF-κB monoclonal antibody diluted in 3% BSA/PBS for
2 h, rinsed three times for 5 min with PBS, and incu-
bated in Alexa Fluor® 488-conjugated secondary anti-
body diluted in 3% BSA/PBS for 1 h. Cells were stained
with 2 μg/mL DAPI and viewed, and images were cap-
tured using an LSM700 laser scanning confocal micro-
scope (Carl Zeiss, Oberkochen, Germany).
Preparation of cytosolic and nuclear extracts
BV-2 cells plated in a 6-well cell culture plates at a dens-
ity of 1 × 106 cells per well were pretreated with or with-
out MME for 2 h and then treated with LPS for 0.5 h.
Cells were washed twice with ice-cold PBS, scraped in
PBS and centrifuged at 13,000 g for 5 min at 4°C. Pellets
were suspended in 180 μL of hypotonic buffer A
[10 mM Tris–HCl (pH 7.4), 10 mM NaCl, 3 mM
MgCl2, 0.02% NaN3, 0.5 mM DTT and 1 mM PMSF]
on ice, and afterward, 20 μL of 5% Nonidet P-40 was
added for 5 min. The mixture was centrifuged at
1,800 g for 5 min. Supernatant was collected as cyto-
solic extract. The pellets were washed with hypotonic
buffer and resuspended in hypertonic buffer C [20 mM 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (pH 7.4),
25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM
EDTA, 0.02% NaN3, 0.5 mM DTT, and 1 mM PMSF] for
1 h on ice and centrifuged at 14,000 g for 10 min. The
supernatant containing nuclear proteins was collected
and stored at −72°C after determination of the protein
concentration.
NF-κB promoter/luciferase assay
Two micrograms of pNF-κB promoter/luciferase DNA
along with 40 ng of control pRL-TK DNA was transi-
ently transfected into 2.0 × 105 BV-2 microglia cells per




Myagropsis myagroides 40.4 ± 2.40 6.84 ±
Sargassum horneri 17.6 ± 1.48 > 10
Sargassum fulvellum 12.1 ± 0.71 53.1 ±
Undaria pinnatifida 9.46 ± 0.86 32.9 ±
Saccharina japonica 9.61 ± 0.03 43.9 ±
Sargachromenol 1.14 ±
All values are duplicated assays ± standard errors for three replicated extractions (i.e
EC50, half maximal effective concentration.
1)Inhibitory activity of NO production in LPS-treated BV-2 cells.
2)Inhibitory activity of ROS generation in LPS-treated BV-2 cells.for 40 h. Cells were treated with MME for 2 h and stim-
ulated with LPS (1 μg/mL) for 6 h. Luciferase activities
of the cells were measured using dual-luciferase assay
system according to the manufacturer’s instructions.
Each transfection was performed in triplicate, and all ex-
periments were repeated at least three times. The lucif-
erase activity was normalized with luciferase activity of
control pRL-TK.
Isolation and identification of sargachromenol from MME
Aliquots of MME were dissolved in methanol and sepa-
rated by Shimadzu high-performance liquid chromatog-
raphy (HPLC) system with Luna RP-18 [Luna C18(2),
5 μm, 250 × 10 mm, Phenomenex, Torrence, CA, USA].
The separation of MME was conducted using 100% metha-
nol (solvent A) and 0.1% formic acid in water (solvent B)
as a mobile phase. The elution profile consisted of a linear
gradient from A/B (78/22) to A/B (95/5) in 90 min and
hold for 10 min and then re-equilibration of the column
with A/B (78/22) for 18 min. The flow rate was
3.5 mL/min at 35°C oven temperature and detection
was performed at 270 nm. Fractions were collected
and assessed for the ability to inhibit NO secretion
using LPS-stimulated BV-2 cells. The isolated compound
(10 mg) was dissolved in 0.6 mL of CDCl3 and used for
1H-
and 13C-NMR spectroscopy. NMR spectra were obtained
by Fourier transform NMR JNM ECP-400 (JEOL, Tokyo,
Japan). The chemical structure of the purified compound
was identified by comparing its data with literature [24].
Statistical analysis
Data were expressed as the means ± SDs of at least three
independent experiments unless otherwise indicated.
Data were analyzed using one-way analysis of variance
(ANOVA), followed by each pair of Student’s t-tests for
multiple comparisons. Differences with a value of p < 0.05
were considered statistically significant. All analyses were
performed using SPSS for Windows, version 10.07 (SPSS,
Chicago, IL, USA)., and yields of ethanolic extracts from the selected brown
ROS2) Yield (%)
, μg/mL) (EC50, μg/mL)
0.78 112.4 ± 8.2 15.9 ± 2.1
0 134.2 ± 15.3 16.0 ± 1.1
1.86 402.1 ± 34.2 13.4 ± 0.79
3.24 240.3 ± 19.3 8.90 ± 0.81
2.95 208.6 ± 16.2 13.4 ± 0.98
0.11 8.31 ± 0.92
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Figure 1 Effect of MME on LPS-induced NO and PGE2
production in BV-2 cells. BV-2 cells pretreated with different
concentrations of MME for 2 h were stimulated with LPS (1 μg/mL)
for 24 h. The treated culture media were used to assay the amount of
NO (A) and PGE2 production (B). BV-2 microglial cells were treated
with various concentration of MME in the absence or presence of
LPS (1 μg/mL). After 24 h, cell viability was measured by MTS
assay (C). Data are presented as means ± SDs of three independent
experiments. ap < 0.05 indicates significant differences compared to
the non-treated group. bp < 0.05 indicates significant differences
compared to the LPS-only group.
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Total phenolic contents and inhibitory activities of the
seaweed extracts on NO and ROS production
M. myagroides and S. horneri showed higher yield of
ethanolic extract than the other seaweeds and M.
myagroides showed highest phenolic contents (Table 1).
Since phenolic compounds are commonly found in plants
and have been reported to have diverse biological activities
including antioxidant and anti-inflammatory activities, we
determined inhibitory activities of ROS and NO produc-
tion of the extracts. M. myagroides showed highest anti-
oxidant activity expressed as ROS scavenging activity
(EC50, 112.4 ± 8.2 μg/mL) and anti-inflammatory activity
expressed as the inhibition of NO production (EC50,
6.84 ± 0.78 μg/mL) in LPS-treated BV-2 cells. Due to
strong anti-inflammatory activity and high phenolic
contents, MME was chosen to investigate the anti-
inflammatory properties and its underlying mechanisms.
MME inhibits NO and PGE2 production in LPS-stimulated
BV-2 cells
To evaluate the effect of MME on LPS-induced produc-
tion of inflammatory mediators including NO and PGE2,
BV-2 cells were pretreated with 0–25 μg/mL MME for
2 h and stimulated with LPS for 24 h. NO production,
measured as nitrite, was increased by LPS, however,
MME significantly reduced NO levels in LPS-stimulated
cells in a dose-dependent manner (p < 0.05, Figure 1A).
Increased PGE2 production by LPS was also significantly
suppressed by MME in a dose-dependent manner with
EC50 value of 8.40 ± 1.08 μg/mL (Figure 1B). To exclude
the possibility that the decreased NO and PGE2 levels
were due to cell death, cytotoxicity of MME was deter-
mined by MTS assay. The result demonstrated that
MME showed no cytotoxicity in BV-2 cells up to 50 μg/mL
(Figure 1C). Thus, the inhibitory effects of MME on NO
and PGE2 production were not due to cytotoxicity.
MME inhibits iNOS and COX-2 expressions in LPS-stimulated
BV-2 cells
To investigate whether the inhibitory effects of MME on
NO and PGE2 production are related to the regulation
of the expression of iNOS and COX-2 proteins, respect-
ively, BV-2 cells were pretreated with the indicated con-
centrations of MME for 2 h and then stimulated with
LPS (1 μg/mL) for 16 h. LPS treatment induced a dra-
matic increase in iNOS and COX-2 proteins, as compared
to the untreated control group (Figure 2A). Pretreatment
of MME strongly inhibited the expression of iNOS and
COX-2 proteins in a dose-dependent manner (p < 0.05).
In addition to protein expression, MME inhibited iNOS
and COX-2 mRNA expression in a dose-dependent man-
ner in LPS-stimulated BV-2 cells (p < 0.05 Figure 2B).





0.01±0.03 1.00±0.05 0.99±0.06 0.87±0.03 0.55±0.02* 0±0.06
0.09±0.02          1.00±0.04          0.69±0.09 *    0.47±0.01*       0.07±0.03*         0±0.01
LPS (1 g/mL)            - +            +             +            +            -
MME ( g/mL)            - - 5            10          25           25
LPS (1 g/mL)            - +            +             +            +            -




0.03±0.05    1.00±0.03          0.72±0.01         0.70±0.02          0 .30±0.06*            0±0.04
0.00±0.02   1.00±0.02          0.571±0.06 *       0.28±0.05*       0 .11±0.04*             0±0.01
B 
Figure 2 Effect of MME on LPS-induced iNOS and COX-2 expressions in LPS-stimulated BV-2 cells. (A) BV-2 cells were pretreated with
different concentrations of MME for 2 h and stimulated with LPS (1 μg/mL) for 16 h. The expression of iNOS, COX-2, and β-actin protein
was detected by Western blot using corresponding antibodies. (B) Cells pretreated with various concentrations of MME for 2 h were
stimulated with LPS (1 μg/mL) for 6 h, and then total RNA was prepared for RT-PCR. The results presented are representative of three
independent experiments. ap < 0.05 indicates significant differences compared to the non-treated group. bp < 0.05 indicates significant
differences compared to the LPS-only group.
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tion of iNOS and COX-2 genes at transcriptional level.
MME inhibits LPS-induced TNF-α, IL-1β, and IL-6 secretion
in BV-2 cells
Since TNF-α, IL-1β, and IL-6 are early secreted pro-
inflammatory cytokines and their levels are up-regulated
in a variety of acute and chronic inflammatory diseases,
we measured the effects of MME on the production of
these cytokines in LPS-stimulated BV-2 cells. To reach
detectable ranges of secreted cytokines in cultured media,
LPS stimulations were extended up to 24 h. The stimula-
tion of BV-2 cells with LPS induced remarkable increase
in TNF-α (Figure 3A), IL-1β (Figure 3B), and IL-6
(Figure 3C). LPS-induced pro-inflammatory cytokines
were significantly decreased by MME pretreatment in
a dose-dependent manner (p < 0.05). The EC50 values
of MME against TNF-α, IL-1β, and IL-6 were estimated
to be 11.8 ± 1.2, 7.55 ± 0.5, and 14.1 ± 1.8 μg/mL, respect-
ively. These results indicate that MME effectively sup-
pressed LPS-induced TNF-α, IL-1β, and IL-6 production,
indicating that MME inhibits the initial phase of the LPS-
stimulated inflammatory response.MME inhibits degradation of IκB-α and translocation of
NF-κB in LPS-stimulated BV-2 cells
To determine transcriptional control of MME, we inves-
tigated the effects of MME on the nuclear translocation
of NF-κB/p65 subunit using LPS-stimulated BV-2 cells.
Confocal microscopic observations revealed that NF-κB/
p65 was mainly located in the cytoplasm in unstimulated
cells. After stimulation with LPS, most cytoplasmic p65
subunit was translocated into the nucleus, as shown in
intense NF-κB/p65 staining in the nucleus (Figure 4A).
However, the level of NF-κB/p65 in the nucleus was
markedly reduced by pretreatment with MME. Consid-
ering the inhibitory effects of MME on LPS-induced
NF-κB translocation into nucleus, we next analyzed the
inhibitory effect of MME on LPS-stimulated phosphoryl-
ation of IκB-α and the translocation of NF-κB by West-
ern blot. LPS treatment induced IκB-α phosphorylation,
responsible for the activation of NF-κB, and MME pre-
treatment suppressed its phosphorylation and recovered
the level of cytosolic IκB-α in a dose-dependent manner
(Figure 4B). As a result of IκB-α phosphorylation, the in-
creased nuclear NF-κB level by LPS was reduced by MME
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Figure 3 Effects of MME on the secretion of pro-inflammatory
cytokines in LPS-stimulated BV-2 cells. BV-2 cells were treated
with various concentrations of MME for 2 h, and then stimulated
with LPS (1 μg/mL) for 24 h. TNF-α (A), IL-1β (B), and IL-6 (C) in the
cultured media were measured by ELISA. Data are means ± SDs of
three independent experiments. ap< 0.05 indicates significant differences
compared to the non-treated group. bp < 0.05 indicates significant
differences compared to the LPS-only group.
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ity of NF-κB in LPS-stimulated cells. The result suggests
that MME pretreatment significantly inhibited LPS-induced NF-κB promoter activity of microglia in a dose-
dependent manner (p < 0.05, Figure 4C). These results in-
dicate that the MME-mediated inhibition of iNOS, COX-2,
and pro-inflammatory cytokine productions were regulated
by the inhibition of NF-κB activation in LPS-stimulated
BV-2 cells.MME inhibits activation of JNK1/2 and ERK1/2 in BV-2
cells
To further investigate the molecular mechanisms of
MME on the inhibition of NF-κB activation in LPS-
stimulated BV-2 cells, we measured the inhibitory effect
of MME on the phosphorylation of MAPKs, which are
associated with the regulation of NF-κB pathway. As
shown in Figure 5A, MME inhibited phosphorylation of
ERK1/2 and JNK1/2 in a dose-dependent manner in
LPS-stimulated cells, whereas there was no marked
effect on the phosphorylation of Akt in BV-2 cells. In
addition, MME slightly reduced p38 MAPK phosphoryl-
ation compared with ERK1/2 and JNK1/2 phosphoryl-
ation. To further confirm the association of these
signaling proteins with the MME’s anti-inflammatory ef-
fect, we compared the production of NO and the protein
levels of iNOS and COX-2 in the presence of MME,
ERK inhibitor (PD98059) or JNK inhibitor (SP600125).
As shown in Figure 5B, the levels of NO secretion from
the LPS-stimulated BV-2 cells were remarkably inhibited
by MME as well as by ERK or JNK inhibitors (p < 0.05). In
addition, pretreatment with MME and SP600125 strongly
inhibited LPS-induced NO production as well as iNOS
and COX-2 production, whereas, pretreatment with
PD98059 moderately inhibited the production of NO and
inflammatory proteins. These results suggest that the add-
itional characteristics of MME to regulated NF-κB path-
way via blocking the phosphorylation of ERK1/2 and
JNK1/2 proteins in response to LPS.Isolation of anti-inflammatory compound from MME
MME was further separated by reverse-phase column
chromatography to identify anti-inflammatory activity
(Figure 6). The peak indicated with sargachromenol
showed a strong anti-inflammatory activity based on
the inhibitory activity of NO production in LPS-treated
BV-2 cells. The peak was collected by the repeated chro-
matographies and the chemical structure of the isolated
compound was identified as sargachromenol from the
comparison of its NMR spectra with the published spec-
tral data. We obtained 4.5 mg of sargachromenol from 1 g
of MME. The purified sargachromenol showed high
anti-inflammatory activity in LPS-stimulated BV-2 cells
(Table 1, EC50, 1.14 ± 0.11 μg/mL), indicating that sarga-
chromenol is one of the major active compounds for anti-
inflammatory activity of MME.
LPS (1 g/mL)




















0.05±0.03 1.00±0.07a 1.04±0.12a 1.00±0.04a 0.65±0.01b 0.08±0.03b
0.21±0.01 1.00±0.04a 0.85±0.08b 0.38±0.05b 0.42±0.03* 0.22±0.02b
10.6±0.09 1.00±0.03 1.9±0.04* 1.74±0.02 * 7.38±0.07* 8.62±0.03
1.32±0.04 1.00±0.06a 1.15±0.03b 1.74±0.04b 2.91±0.04b 2.77±0.08b
LPS (1 g/mL)            - +              +             +             +              -


































LPS (1 g/mL)            - +               +              +               +             -
MME ( g/mL)            - - 5              10             25           25
Figure 4 Effect of MME on the translocation and activation of NF-κB in LPS-stimulated BV-2 cells. (A) Cells were treated with and without
MME for 2 h followed by LPS stimulation for 30 min. NF-κB/p65 subunits were probed by anti-NF-κB antibody and Alexa Fluor® 488-conjugated
secondary antibody. The nuclei were stained by DAPI and the images were captured by confocal microscopy (×40). (B) Cells pretreated with
different concentrations of MME for 2 h were stimulated with LPS for 30 min. Cytosolic and nuclear extracts were prepared and analyzed
using Western blot by using corresponding antibodies. (C) Cells were co-transfected with 2 μg of NF-κB promoter-containing luciferase
DNA along with 40 ng of control pRL-TK DNA for 40 h. Transfected cells were pretreated with various concentrations of MME for 2 h and
then stimulated with LPS for 6 h. Cell lysates were prepared and used for reporter gene assay. Data are means ± SDs of three independent
experiments. ap < 0.05 indicates significant differences compared to the non-treated group. bp < 0.05 indicates significant differences compared
to the LPS-only group.
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Brown seaweeds and their extracts are a well-known
sources of antioxidation or anti-inflammation due to
their appreciable amount of polyphenols and pigments.
Although significant differences were observed in both
total polyphenolic contents and antioxidant activities of
extracts from various species, high correlation was found
between total polyphenolic contents and their antioxidant
capacity to scavenge ROS [29]. Polyphenolic compounds
from marine algae may prevent inflammatory disorders,
cancer, and diabetes which are associated with the regula-
tion of free radicals generated in the cells [30,31]. In this
regard, we analyzed antioxidant and anti-inflammatoryactivities of five representative brown algae along the
southeastern coast of Korea. Among them, M. myagroides
showed the highest phenolic contents and ROS scaven-
ging activity as well as anti-inflammatory activity. High
phenolic content in M. myagroides may participate in the
inhibition of NO production in LPS-treated BV-2 cells. As
anti-inflammatory activities from M. myagroides, fucoxan-
thin [32], fatty acid [33], 6,6-bieckol [22], and phlorofucofur-
oeckol B [21] have shown potent activities in macrophage
or microglial cells. However, anti-inflammatory activity
of MME in this study may not be due to fucoxanthin,
fatty acid or phlorotannins, since the peaks of those










0.16±0.05 1.00±0.1a 0.63±0.07b 0.43±0.03b 0.11±0.02b 0.04±0.01b
0.22±0.03 1.00±0.07a 0.51±0.05b 0.53±0.05b 0.07±0.01b 0.03±0.01b
0.20±0.01 1.00±0.11a 1.07±0.10a 0.78±0.068b 0.75±0.08b 0.72±0.07b
0.77±0.06 1.00±0.1a 0.95±0.10a 1.07±0.11a 1.03±0.10a 1.01±0.12a
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0.01±0.02 1.00±0.03a 0.52±0.03b 0.78±0.03b 0.41±0.02b
0.00±0.04 1.00±0.05a 0.1±0.02b 0.84±0.06b 0.11±0.04b
B
Figure 5 Effects of MME on the phosphorylations of MAPKs
and Akt in LPS-stimulated BV-2 cells. (A) Cells were treated with
various concentrations of MME for 2 h, and then stimulated with
LPS (1 μg/mL) for 30 min. Whole cell lysates were prepared and
analyzed by Western blot. Relative density ratios of pERK, pJNK, pp38
MAPK, and pAkt over ERK, JNK, p38 MAPK, and Akt, respectively, are
shown below the blots. (B) Cell pretreated with indicated
concentrations of MME or inhibitors for 2 h were stimulated with
LPS (1 μg/mL) for 16 h. The culture media were collected for
measuring NO, and total cell lysates were prepared for Western blot
analysis. The results presented are representative of three
independent experiments. Graphs represent means ± SDs of three
independent experiments. ap < 0.05 indicates significant differences
compared to the non-treated group. bp < 0.05 indicates significant
differences compared to the LPS-only group.
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inflammatory compounds are contained in MME and
we separated the components from MME using C18
column and isolated sargachromenol having strong
anti-inflammatory activity (Table 1). Base on the in-
hibitory activity of NO production in LPS-stimulated
BV-2 cells, sargachromenol might be a main anti-
inflammatory compound in MME.
NO and PGE2 are crucial inflammatory and neurotoxic
mediators. These inflammatory mediators are respon-
sible for the harmful effects on brain diseases, including
ischemia, Alzheimer’s disease, and neuronal death [34].
In vitro and in vivo studies have revealed that overproduc-
tions of NO and PGE2 by enhanced iNOS and COX-2
protein levels, are associated with central nervous injuries
and diseases [6]. iNOS and COX-2 proteins have been
over-expressed in microglial cells from the rodent brain
treated with LPS [2]. In addition, iNOS and COX-2 inhibi-
tors provide neuroprotective effects against LPS-induced
neurotoxicity, suggesting NO and PGE2 have important
roles in neurotoxicity [6,35]. In this regard, inhibition of
inflammatory mediator production is considered as a key
step in the control of neuroinflammatory diseases. In the
present study, we demonstrated that MME inhibited pro-
ductions of both NO and PGE2 in LPS-stimulated BV-2
cells (Figure 1). Moreover, we provide evidence that
MME-mediated inhibition of NO and PGE2 production
was the consequence of the suppression of both mRNA
and protein levels of iNOS and COX-2 in LPS-stimulated
BV-2 cells (Figure 2). Furthermore, we found that the sup-
pression of COX-2 mRNA expression by MME was more
marked than that of COX-2 protein in BV-2 cells, indicat-
ing that inhibition of PGE2 by MME is associated with
downregulation of COX-2 at both transcriptional and
translational levels in LPS-stimulated BV-2 cells. Thus,
the present findings may address that MME has pro-
tective effects on neurodegenerative diseases induced
by neuroinflammation.
Pro-inflammatory cytokines, including TNF-α, IL-1β,
and IL-6 are small secreted proteins that regulate im-
munity and inflammation. Their production is increased
in inflammatory states and they function by regulating
the intensity and duration of the immune response [3].
TNF-α plays a central role in initiating and regulating
the cytokine signaling cascade during an inflammatory
response in neuronal cells. In inflammatory disease states,
TNF-α along with other pro-inflammatory mediators and
neurotoxic substances is predominantly produced by acti-
vated microglia [4]. IL-1β is an important initiator of the
immune response, playing a key role in the onset and de-
velopment of a complex hormonal and cellular inflamma-
tory cascade. IL-6 is a multifunctional cytokine that plays
an important role in host defense, with major regulatory
effects upon the inflammatory response [36]. Excessive
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Figure 6 Representative HPLC chromatogram of MME. Aliquots of MME were separated by HPLC system and peak was identified by
comparison of retention time to the corresponding authentic standard (inlet).
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microglia and lead to neural cell deaths, resulting in the
pathogenesis of several neurological and neurodegenera-
tive disorders [4,6,37]. As an alternative chemoprevention
of inflammatory diseases, natural compounds able to in-
hibit the production of pro-inflammatory cytokines may
be attractive as anti-inflammatory agents and, for this rea-
son, the inhibitory effects of phytochemicals on the produc-
tion of pro-inflammatory cytokines have been intensively
studied to develop anti-inflammatory agents for preventing
inflammatory diseases [38]. In the present study, we have
demonstrated that MME remarkably suppressed the secre-
tions of TNF-α, IL-1β, and IL-6 in LPS-stimulated BV-2
cells (Figure 3). Thus, the present findings may further sup-
port the potential of MME as a neuroprotective by reducing
inflammation.
NF-κB plays an important role in the regulation of cell
survival and coordinates the expression of pro-inflammatory
proteins and cytokines, including iNOS, COX-2, TNF-α,
IL-1β, and IL-6 [8]. NF-κB is present as an inactive
complex associated with an inhibitory subunit, IκB-α,
in cytoplasm. Activation of NF-κB caused by LPS or
pro-inflammatory cytokines leads to degradation of IκB-α
and inducing translocation of NF-κB into nucleus [12]. Re-
cently, we demonstrated that extract of brown algae includ-
ing Saccharina japonica [19,20], M. myagroides [21,22],
Ecklonia stolonifera [15], and Sargassum fulvellum [39]
inhibited the activation of NF-κB signaling pathway
through the blockade of proteolytic degradation of
IκB-α. In this study, we observed that enhanced phos-
phorylation of IκB-α by LPS was reduced by MMEtreatment, suggesting that MME protected the proteo-
lytic degradation of IκB-α (Figure 4B). Degradation of
IκB-α involves its dissociation from the inactive com-
plex, leading to activation of NF-κB in response to
LPS, which is demonstrated by NF-κB promoter activ-
ity (Figure 4C). Moreover, the nuclear translocation of
NF-κB was significantly inhibited by MME, supporting
the inhibition of NF-κB activation by MME (Figure 4A).
From these data, the MME-mediated down-expression
of LPS-induced inflammatory mediators and cytokines
in BV-2 cells is partially associated with the ability of
MME to inhibit the IκB/NF-κB signaling pathway.
NF-κB activation is alternatively regulated by various
cellular kinases including MAPKs and Akt, which are
the groups of protein kinases to play key roles in inflam-
matory reactions [38,40]. MAPKs are involved in inflam-
matory signaling cascades and regulation of iNOS and
COX-2 through the activation of NF-κB in LPS-stimulated
immune cells [9,12,38]. Therefore, anti-inflammatory mech-
anisms are closely related to inhibition of MAPKs in stimu-
lated BV-2 cells. In this study, we have specifically shown
that MME inhibits the activation of ERKs and JNKs, but not
Akt and little p38 MAPK, in response to LPS in BV-2 cells,
suggesting that ERKs and JNKs are additional targets of
MME. Although, hexane fraction of MME down-regulated
the phosphorylation of MAPKs and Akt in LPS-stimulated
RAW 264.7 cells [22], it is hard to conclude why MME did
not inhibit the phosphorylation of p38 MAPK and Akt in
LPS-stimulated BV-2 cells. To further confirm the involve-
ment of ERK1/2 and JNK1/2 on the activation of NF-κB,
NO production and iNOS and COX-2 expression were
Kim et al. BMC Complementary and Alternative Medicine 2014, 14:231 Page 11 of 12
http://www.biomedcentral.com/1472-6882/14/231determined. The inhibitory level of NO production showed
45% in the PD98059 treated cells and 65% in the SP600125
treated cells. MME treatment showed higher inhibitory ef-
fect of NO production than both inhibitors, which indicates
that MME inhibits both phosphorylation of ERK1/2 and
JNK1/2 (Figure 5B). In addition, treatment of both in-
hibitors resulted in suppression of iNOS and COX-2 expres-
sions. Considering roles of MAPKs in inflammatory gene
expression, MME inhibited, at least in part, LPS-induced
NF-κB activation in the microglial cells by inhibiting the
JNK and ERK pathways.Conclusions
We have demonstrated that sargachromenol-rich MME in-
hibits the production of NO, PGE2, and pro-inflammatory
cytokines as well as iNOS and COX-2 at transcriptional and
translational levels. Anti-inflammatory action of MME on
LPS-stimulated BV-2 cells was associated with blocking IκB/
NF-κB, JNK, and ERK pathways. Verification and confirm-
ation of its anti-inflammatory activity and relative mechan-
ism at the cellular and molecular levels will be beneficial for
the further application of MME in therapeutic agents for
neuroinflammation in neurodegenerative diseases. Future
studies will be necessary in order to determine the bioavail-
ability of this preparation and metabolites in animal tissue.
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